key: cord-0323189-ojwy2bl2 authors: Nasir, A.; Aamir, U. B.; Kanji, A.; Samreen, A.; Ansar, Z.; Ghanchi, N.; Bukhari, A. R.; Masood, K. I.; Islam, N.; Ghanic, S.; Syed, M. A.; Wassan, M.; Mahmood, S. F.; Hasan, Z. title: SARS-CoV-2 Variants of Concern (VOC) Alpha, Beta, Gamma, Delta, and Omicron coincident with consecutive pandemic waves in Pakistan date: 2022-05-22 journal: nan DOI: 10.1101/2022.05.19.22275149 sha: 337839ebb07b5d5732fe1dc19c89b21707b86ed8 doc_id: 323189 cord_uid: ojwy2bl2 Identification and monitoring of SARS-CoV-2 Variants of Concern/Interest (VOC/VOIs) is essential to guide public health measures. We report the surveillance of VOCs circulating in Karachi during the pandemic between April 2021 and February 2022. We screened 2150 SARS-CoV-2 PCR positive samples received at the AKUH Clinical Laboratories. VOC was identified using a PCR-based approach targeting lineage-specific mutations using commercially available assays. Of the SARS-CoV-2 PCR positive samples, 81.7% had VOC/VOI, while 18.3% were undetermined. Alpha variants were predominant at 82.5% and 40.3% of the cases in April and May 2021. Beta variants increased in May (29%) and June (42%) and then reduced to 6% by July. Gamma variant cases were at 14.5% and 9% in May and June, respectively. Delta variants first detected in May, increased to comprise 66% of all variants by July, remaining dominant in August, September, October, and November 2021 at 88%, 91%, 91% and 85% respectively. Omicron (BA.1) variants emerged in December, rising to 42% of cases with an increase to 81% by January 2022 and then reducing to 45% in February 2022. Delta variant prevalence was coincident with increased hospital admissions and mortality. The Omicron variant surge was associated with increased daily infections but limited COVID-19 severity. We highlight the predominance of the VOCs identified through a rapid PCR based approach. As this is important to inform a public health response, we propose that a mutation targeted approach can be a rapid, lower cost solution to aid tracking of known VOCs during pandemic waves. Viral infections are a major global health concern, and new infectious diseases continue to emerge that affect public health. SARS-CoV-2 (previously known as 2019-nCoV), a strain belonging to the coronavirus family that originated in Wuhan, China in December 2019 1, 2 has spread to multiple countries around the world and the disease associated with SARS-CoV-2 (COVID-19) is a public health emergency of international concern. According to John Hopkins as its fifth variant of concern (VOC) 10 . According to a WHO report, the Omicron variant is surpassing the Delta variant as the globally dominant variant and contributing significantly to immune evasion 11 and antibody evasion 12 . The gold standard to confirm VOC is through sequencing, however routine genomic surveillance in resource-limited countries like Pakistan is not always readily available. Genomic sequencing is costly and requires complex technical instrumentation and expertise. Coupled with increased global demand and shortage of reagents, sequencing remains a challenge in middle-income countries such as Pakistan. Alternately, PCR-based detection of lineage-specific target mutations can be used to identify known VOCs 13, 14 . World Health Organization, Pakistan supported the implementation of genomic surveillance for SARS-CoV2 at major diagnostic laboratories including Aga Khan University Hospital (AKUH) as part of a national consortium coordinated by the National Reference Public Health Laboratory at the National Institute of Health, Islamabad. Sequencing of SARS-CoV-2 strains had identified the introduction of VOC in Pakistan 15-17 ; it was not possible to scale up the whole genome sequencing effort country wide to trace and track variants due to resource limitations. Therefore, we applied lineage-specific mutation-specific PCR approach to identify VOC in SARS-CoV-2 PCR positive samples. Sindh province has accounted for 37% of the COVID19 positive cases in Pakistan (https://covid.gov.pk/stats/pakistan). Karachi with 20 million population has been found to comprise 81% of COVID-19 cases across Sindh (https://www.sindhhealth.gov.pk/daily_situation_report). Hence, we focused on samples received at the AKUH Clinical Laboratory from Karachi between April 2021 and February 2022. Using this approach, we were able to identify the emergence of the Alpha, Beta, Gamma, Delta, and more recently of the Omicron variants through the period studied. The objective of this study was to allow for early detection of circulating SARS-CoV2 variants in Pakistan. This study received approval from the Ethical Review Committee, The Aga Khan University (AKU). Diagnostic testing of respiratory specimens was conducted at the AKU Hospital Clinical Laboratories, Karachi using the COBAS® SARS-CoV-2 assay (COBAS® 6800 Roche All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. For this study we recruited samples received at the AKUH Clinical Laboratories from all over Karachi. On each day between April 2021 and February 2022, a retrospective review of positive SARS-CoV-2 specimens from the previous day was conducted. The first 10 positive specimens were identified and collected through consecutive convenience sampling. For VOC testing, RNA was extracted using the QiaAmp RNA MiniKit, Qiagen, according to the manufacturer's instructions. Briefly, 280 µl NPA was added to 1120 µl AVL buffer without carrier RNA and allowed to incubate for 10 minutes. Next, 560 µl ethanol was added and the mixture was applied to QIAamp Mini column. After spin, the flow through was discarded and washing steps with 500 µl AW1 and 500 µl AW2 buffers were performed. The RNA was eluted in 40 µl AVE buffer and (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 1B. Clinical Laboratories, Karachi between February 2020 and February 2022. Figure 1A , the graph depicts the number of SARS-CoV-2 PCR positive respiratory samples reported daily by All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. Figure 1B , National data available on the NCOC, government website for the period is depicted. With an increase in the number of SARS-CoV-2 positive cases at different stages of the pandemic, it was imperative to identify the VOC in the population as a tool for Public Health surveillance. The timeline of the introduction of the assays between April 2021 and February 2022 and the screening workflow is provided in Supplementary Figures 1 and 2 Table 6 ). Identification of SARS-CoV-2 variant cases was reported on a weekly basis to the Health Department (NIH Situational Reports on the variants identified is available, All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. June (42%) and then reduced to 6% by July. Gamma variants cases were at 14.5% and 9% in May and June, respectively. Delta variants first detected in May, increased to comprise 66% of all variants by July, remaining dominant in August, September, October, and November 2021 at 88%, 91%, 91% and 85% respectively. Omicron (BA.1) variants emerged in December, rising to 42% of cases with an increase to 81% by January 2022 and then reducing to 45% in February 2022. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The AKUH Clinical laboratories received samples for COVID19 PCR testing from all over Karachi and here we focused on those received from Karachi to monitor the spread of VOC through the pandemic. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. had increased to over 50% during the fifth wave. Booster doses had also been introduced, just All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. prior to the fifth wave. On the other hand, the exact contribution of the inherent ability of the Omicron variant to cause severe disease is still under investigation. It is postulated that this may be due to a lack of mutations at the ORF3a gene compared to the previous VOCs 23 , though this is yet to be proven. However, scaling up of SARS-CoV-2 sequencing is limited by technical and financial capacity of countries. We have demonstrated that a PCR-based targeted approach can be used to monitor VOCs in a low-resource setting. However, this approach is unable to fully characterize multiple genetic variations of SARS-CoV-2 lineages and study viral evolution 26 . Furthermore, this method cannot identify minor and novel variants and several strains were 'undetermined'. Also, as specimens selected for variant screening had lower Ct values, those with a high Ct or lower viral loads may be missed, resulting in an over-representation of VOC. The sample size of our study was relatively small, but the sampling was consistent across the study period. Therefore, the trends in VOC, we observed were similar to those observed elsewhere in Pakistan 27, 28 and therefore likely representative across the period A great advantage of the PCR targeted mutation approach is that it allows for the identification of variants in samples with relatively lower viral loads as compared with sequencing. Wholegenome Sequencing of SARS-CoV-2 requires input RNA from samples of low CT values (high viral loads) preferable CT 30 and lower 29 . Consequently, this would preclude variant analysis of All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In the future, once a new or emerging variant has been identified by genomic sequencing, it can be tracked using a SARS-CoV-2 variant, PCR-based targeted. This would allow rapid and lowcost evaluation of its transmission. were identified with a PCR based approach targeting lineage specific mutations using commercially available assays. Supplementary Tables 1 to 6 present the specificity target of the probes/primers sequences and their target mutation of these assays as provided by the manufacturer. Supplementary (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. A novel coronavirus outbreak of global health concern Clinical characteristics of COVID-19 in patients with preexisting ILD: A retrospective study in a single center in Wuhan COVID-19 Data Repository by the Center for Systems Science and Engineering (CSSE) at COVID-19 Trends and Forecast in the Eastern Mediterranean Region With a Particular Focus on Pakistan SARS-CoV-2 Variant Classifications and Definitions Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization WHO. Tracking SARS-CoV-2 variants SARS-CoV-2 delta variant: a persistent threat to the effectiveness of vaccines The Global Epidemic of the SARS-CoV-2 Delta Variant, Key Spike Mutations and Immune Escape Enhancing response to Omicron SARS-CoV-2 variant: Technical brief and priority actions for Member States. World Health Organization Headquarters Antibody evasion properties of SARS-CoV-2 Omicron sublineages Developing an Amplification Refractory Mutation System-Quantitative Reverse Transcription-PCR Assay for Rapid and Sensitive Screening of SARS-CoV-2 Variants of Methods for the detection and characterization of SARS-CoV-2 variants: first update No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted Alpha VOC/B. 1.1. 7 in Pakistan Through International Travelers. Virus Evolution Genomic surveillance of SARS-CoV-2 reveals emergence of Omicron BA. 2 in Islamabad Tracking down B.1.351 SARS-CoV-2 variant in Pakistan through genomic surveillance Emerging Variants Bioinformatic Working G, Strain S, Emerging Variants NSWG. Genomic Surveillance for SARS-CoV-2 Variants: Predominance of the Delta (B.1.617.2) and Omicron (B.1.1.529) Variants -United States SARS-COV-2 SYMPTOMS IN THE UNITED KINGDOM. medRxiv Decreased severity of disease during the first global omicron variant covid-19 outbreak in a large hospital in tshwane, south africa Comparative analysis of the risks of hospitalisation and death associated with SARS-CoV-2 omicron (B.1.1.529) and delta (B.1.617.2) variants in England: a cohort study Decoupling of omicron variant infections and severe COVID-19 Understanding the Role of SARS-CoV-2 ORF3a in Viral Pathogenesis and COVID-19 Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health Higher entropy observed in SARS-CoV-2 genomes from the first COVID-19 wave in Pakistan Limitation of Screening of Different Variants of SARS-CoV-2 by RT-PCR. Diagnostics (Basel) Genomic surveillance reveals the detection of SARS-CoV-2 delta, beta, and gamma VOCs during the third wave in Pakistan SARS-CoV-2 UK, South African and Brazilian Variants in Karachi-Pakistan. Frontiers in Molecular Biosciences. 2021. 29. Organization WH. Genomic sequencing of SARS-CoV-2: a guide to implementation for maximum impact on public health We thank for the following their support in this surveillance initiative; the AKUH Clinical Laboratory particularly, Naima Maniar, Sohail Baloch. Thanks also to the COVID-19 testing staff at the Section of Molecular Pathology, AKUH. This work received support through a University Research Council Grant, Aga Khan University, Pakistan and the World Health Organization, Pakistan. The authors have no conflicts of interest to declare. All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted May 22, 2022.